Skip to main content
Caplight Logo









Torpedo Therapeutics

Torpedo Therapeutics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.torpedotherapeutics.com/

Last Round

Grant

Nov 5, 2025

Total Funding Raised

$1.19M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Torpedo Therapeutics is a biotechnology company developing high-precision, closed-loop deep brain stimulation devices to treat neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

deep brain stimulationDBSclosed-loop neuromodulationimplantable medical devicebrain-computer interfaceBCIneurotechnologymedical AIprecision medicineneural sensingneurological disorder treatmentsmart implantsbioelectronicsmicro-fabricated electrodeshealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Torpedo Therapeutics Comparables

Compare Torpedo Therapeutics with similar companies based on industry and business-model similarity.

Torpedo Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
INBRAIN Neuroelectronics
79%
Amber Therapeutics
79%
Newronika
78%

Torpedo Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 5, 2025
AcceleratorFeb 1, 2022
AcceleratorJan 1, 2022

Torpedo Therapeutics Investors

Notable investors and investment history

Torpedo Therapeutics investors
InvestorRounds
Y CombinatorAccelerator
Northeast Microelectronics Coalition HubGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 5, 2025

    $187K grant received from Northeast Microelectronics Coalition Hub

  • Feb 1, 2022

    $500K round led by Y Combinator

Torpedo Therapeutics Filings

Explore SEC and related filing metadata, where available.

Torpedo Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Torpedo Therapeutics's valuation, stock price, and market status.

Is Torpedo Therapeutics a public or private company?

Torpedo Therapeutics is a private company.

What is the current stock price of Torpedo Therapeutics?

Torpedo Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Torpedo Therapeutics worth (valuation)?

Valuation information for Torpedo Therapeutics is not publicly available.

Can I buy Torpedo Therapeutics stock?

Torpedo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Torpedo Therapeutics's last funding round?

Torpedo Therapeutics's most recent funding round was Seed on February 17, 2022.

Who are the main investors in Torpedo Therapeutics?

Key investors in Torpedo Therapeutics include Y Combinator.

Will Torpedo Therapeutics IPO soon?

No public IPO plans have been announced for Torpedo Therapeutics.

How can I track Torpedo Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Torpedo Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range3
Year Founded2018
Last FundingNov 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?